Clinical trial for Deep Vein Thrombosis
Official title Diagnosing Deep-vein Thrombosis Early in Critically Ill Patients
ClinicalTrials.gov ID: NCT05112705
What this study is testing
- What it's testing
- The study wants to see if regular ultrasound checks can lower the chance of lung clots and death within 90 days.
- Who it's for
- Adults who are critically ill and at risk for deep‑vein blood clots.
- What's involved
- Participants receive scheduled ultrasound exams to look for clots, in addition to standard medical care.
- Time commitment
- Patients are followed for up to 90 days, with ultrasound visits during their intensive care stay.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Medical, surgical or trauma ICU patients ≥18 years old.
- Patients who are expected to stay in the ICU more than 2 calendar days (unlikely to be discharged out of ICU on the day of admission or on the next...
You likely can't join if
- Patients with DVT or PE diagnosed within the last year.
- Patients receiving chronic systemic anticoagulation.
- Patients who have received up to the time of ICU admission or are receiving therapeutic doses of anticoagulation with UFH, LMWH, or other...
- Inability or contraindication to obtain adequate ultrasound on the lower extremities (Burns in the lower extremities, lacerations, active skin...
- Patients with Inferior Vena Cava (IVC) Filter.
- Known or suspected pregnancy.
See the full eligibility criteria
- Medical, surgical or trauma ICU patients ≥18 years old.
- Patients who are expected to stay in the ICU more than 2 calendar days (unlikely to be discharged out of ICU on the day of admission or on the next day).
- Patients with DVT or PE diagnosed within the last year.
- Patients receiving chronic systemic anticoagulation.
- Patients who have received up to the time of ICU admission or are receiving therapeutic doses of anticoagulation with UFH, LMWH, or other anticoagulants.
- Inability or contraindication to obtain adequate ultrasound on the lower extremities (Burns in the lower extremities, lacerations, active skin infection, \& ischemic limb in the legs, large dressings in the thighs that...
- Patients with Inferior Vena Cava (IVC) Filter.
- Known or suspected pregnancy.
- Limitation of life support, life expectancy \<7 days or palliative care.
- Previously enrolled in DETECT trial within the last 180 days.
- Enrolled in another trial for which co-enrolment is not approved.
The study team makes the final eligibility decision.
Where it is enrolling
- Riyadh, Riyadh Region, Saudi Arabia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Riyadh, Riyadh Region, Saudi Arabia. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.